BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1043 related articles for article (PubMed ID: 18996173)

  • 1. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of sensorimotor integration during locomotion toward a target in Parkinson's disease.
    Almeida QJ; Frank JS; Roy EA; Jenkins ME; Spaulding S; Patla AE; Jog MS
    Neuroscience; 2005; 134(1):283-93. PubMed ID: 15950389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Parkinson's disease on proprioceptively based on-line movement control.
    Mongeon D; Blanchet P; Bergeron S; Messier J
    Exp Brain Res; 2015 Sep; 233(9):2707-21. PubMed ID: 26055990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug treatment and familiar music aids an attention shift from vision to somatosensation in Parkinson's disease on the reach-to-eat task.
    Sacrey LA; Travis SG; Whishaw IQ
    Behav Brain Res; 2011 Mar; 217(2):391-8. PubMed ID: 21073905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential progression of proprioceptive and visual information processing deficits in Parkinson's disease.
    Keijsers NL; Admiraal MA; Cools AR; Bloem BR; Gielen CC
    Eur J Neurosci; 2005 Jan; 21(1):239-48. PubMed ID: 15654861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations.
    Mongeon D; Blanchet P; Messier J
    Brain Cogn; 2013 Mar; 81(2):271-82. PubMed ID: 23313834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multisensory determinants of orientation perception in Parkinson's disease.
    Barnett-Cowan M; Dyde RT; Fox SH; Moro E; Hutchison WD; Harris LR
    Neuroscience; 2010 Jun; 167(4):1138-50. PubMed ID: 20206672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic modulation of timing control and variability in the gait of Parkinson's disease.
    Almeida QJ; Frank JS; Roy EA; Patla AE; Jog MS
    Mov Disord; 2007 Sep; 22(12):1735-42. PubMed ID: 17557356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manual transport in Parkinson's disease.
    Hejduková B; Hosseini N; Johnels B; Ingvarsson PE; Steg G; Olsson T
    Mov Disord; 2003 May; 18(5):565-72. PubMed ID: 12722171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proprioceptive impairment and postural orientation control in Parkinson's disease.
    Vaugoyeau M; Hakam H; Azulay JP
    Hum Mov Sci; 2011 Apr; 30(2):405-14. PubMed ID: 21419506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hand preshaping in Parkinson's disease: effects of visual feedback and medication state.
    Schettino LF; Adamovich SV; Hening W; Tunik E; Sage J; Poizner H
    Exp Brain Res; 2006 Jan; 168(1-2):186-202. PubMed ID: 16041510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perception of active and passive turning in Parkinson disease.
    Earhart GM; Stevens ES; Perlmutter JS; Hong M
    Neurorehabil Neural Repair; 2007; 21(2):116-22. PubMed ID: 17312086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired reproduction of second but not millisecond time intervals in Parkinson's disease.
    Koch G; Costa A; Brusa L; Peppe A; Gatto I; Torriero S; Gerfo EL; Salerno S; Oliveri M; Carlesimo GA; Caltagirone C
    Neuropsychologia; 2008 Apr; 46(5):1305-13. PubMed ID: 18215403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic medication boosts action-effect binding in Parkinson's disease.
    Moore JW; Schneider SA; Schwingenschuh P; Moretto G; Bhatia KP; Haggard P
    Neuropsychologia; 2010 Mar; 48(4):1125-32. PubMed ID: 20018200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural basis for impaired time reproduction in Parkinson's disease: an fMRI study.
    Elsinger CL; Rao SM; Zimbelman JL; Reynolds NC; Blindauer KA; Hoffmann RG
    J Int Neuropsychol Soc; 2003 Nov; 9(7):1088-98. PubMed ID: 14738289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postural reactions to soleus muscle vibration in Parkinson's disease: scaling deteriorates as disease progresses.
    Valkovic P; Krafczyk S; Bötzel K
    Neurosci Lett; 2006 Jun; 401(1-2):92-6. PubMed ID: 16574321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.
    Palmer SJ; Eigenraam L; Hoque T; McCaig RG; Troiano A; McKeown MJ
    Neuroscience; 2009 Jan; 158(2):693-704. PubMed ID: 18722512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic influence on disturbed spatial discrimination in Parkinson's disease.
    Shin HW; Kang SY; Sohn YH
    Mov Disord; 2005 Dec; 20(12):1640-3. PubMed ID: 16092109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.